237 related articles for article (PubMed ID: 32226534)
1. Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study.
Voskuil FJ; de Jongh SJ; Hooghiemstra WTR; Linssen MD; Steinkamp PJ; de Visscher SAHJ; Schepman KP; Elias SG; Meersma GJ; Jonker PKC; Doff JJ; Jorritsma-Smit A; Nagengast WB; van der Vegt B; Robinson DJ; van Dam GM; Witjes MJH
Theranostics; 2020; 10(9):3994-4005. PubMed ID: 32226534
[TBL] [Abstract][Full Text] [Related]
2. Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer.
Nishio N; van den Berg NS; van Keulen S; Martin BA; Fakurnejad S; Zhou Q; Lu G; Chirita SU; Kaplan MJ; Divi V; Colevas AD; Rosenthal EL
Mol Imaging Biol; 2020 Feb; 22(1):156-164. PubMed ID: 31054001
[TBL] [Abstract][Full Text] [Related]
3. The Sentinel Margin: Intraoperative
van Keulen S; Nishio N; Birkeland A; Fakurnejad S; Martin B; Forouzanfar T; Cunanan K; Colevas AD; S van den Berg N; Rosenthal E
Clin Cancer Res; 2019 Aug; 25(15):4656-4662. PubMed ID: 31142505
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer.
Rosenthal EL; Moore LS; Tipirneni K; de Boer E; Stevens TM; Hartman YE; Carroll WR; Zinn KR; Warram JM
Clin Cancer Res; 2017 Aug; 23(16):4744-4752. PubMed ID: 28446503
[No Abstract] [Full Text] [Related]
5. Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers.
Gao RW; Teraphongphom N; de Boer E; van den Berg NS; Divi V; Kaplan MJ; Oberhelman NJ; Hong SS; Capes E; Colevas AD; Warram JM; Rosenthal EL
Theranostics; 2018; 8(9):2488-2495. PubMed ID: 29721094
[No Abstract] [Full Text] [Related]
6. Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study.
Lu G; van den Berg NS; Martin BA; Nishio N; Hart ZP; van Keulen S; Fakurnejad S; Chirita SU; Raymundo RC; Yi G; Zhou Q; Fisher GA; Rosenthal EL; Poultsides GA
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):753-764. PubMed ID: 32416764
[TBL] [Abstract][Full Text] [Related]
7. Back-Table Fluorescence-Guided Imaging for Circumferential Resection Margin Evaluation Using Bevacizumab-800CW in Patients with Locally Advanced Rectal Cancer.
de Jongh SJ; Tjalma JJJ; Koller M; Linssen MD; Vonk J; Dobosz M; Jorritsma-Smit A; Kleibeuker JH; Hospers GAP; Havenga K; Hemmer PHJ; Karrenbeld A; van Dam GM; van Etten B; Nagengast WB
J Nucl Med; 2020 May; 61(5):655-661. PubMed ID: 31628218
[TBL] [Abstract][Full Text] [Related]
8. Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer.
Rosenthal EL; Warram JM; de Boer E; Chung TK; Korb ML; Brandwein-Gensler M; Strong TV; Schmalbach CE; Morlandt AB; Agarwal G; Hartman YE; Carroll WR; Richman JS; Clemons LK; Nabell LM; Zinn KR
Clin Cancer Res; 2015 Aug; 21(16):3658-66. PubMed ID: 25904751
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence-Guided Visualization of Soft-Tissue Sarcomas by Targeting Vascular Endothelial Growth Factor A: A Phase 1 Single-Center Clinical Trial.
Steinkamp PJ; Pranger BK; Li MF; Linssen MD; Voskuil FJ; Been LB; van Leeuwen BL; Suurmeijer AJH; Nagengast WB; Kruijff S; van Ginkel RJ; van Dam GM
J Nucl Med; 2021 Mar; 62(3):342-347. PubMed ID: 32680922
[TBL] [Abstract][Full Text] [Related]
11. Effects of an Unlabeled Loading Dose on Tumor-Specific Uptake of a Fluorescently Labeled Antibody for Optical Surgical Navigation.
Moore LS; Rosenthal EL; de Boer E; Prince AC; Patel N; Richman JM; Morlandt AB; Carroll WR; Zinn KR; Warram JM
Mol Imaging Biol; 2017 Aug; 19(4):610-616. PubMed ID: 27830425
[TBL] [Abstract][Full Text] [Related]
12. Characterizing the detection threshold for optical imaging in surgical oncology.
Prince AC; Jani A; Korb M; Tipirneni KE; Kasten BB; Rosenthal EL; Warram JM
J Surg Oncol; 2017 Dec; 116(7):898-906. PubMed ID: 28628728
[TBL] [Abstract][Full Text] [Related]
13. First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800.
Miller SE; Tummers WS; Teraphongphom N; van den Berg NS; Hasan A; Ertsey RD; Nagpal S; Recht LD; Plowey ED; Vogel H; Harsh GR; Grant GA; Li GH; Rosenthal EL
J Neurooncol; 2018 Aug; 139(1):135-143. PubMed ID: 29623552
[TBL] [Abstract][Full Text] [Related]
14. EGFR-targeted fluorescence molecular imaging for intraoperative margin assessment in oral cancer patients: a phase II trial.
de Wit JG; Vonk J; Voskuil FJ; de Visscher SAHJ; Schepman KP; Hooghiemstra WTR; Linssen MD; Elias SG; Halmos GB; Plaat BEC; Doff JJ; Rosenthal EL; Robinson D; van der Vegt B; Nagengast WB; van Dam GM; Witjes MJH
Nat Commun; 2023 Aug; 14(1):4952. PubMed ID: 37587149
[TBL] [Abstract][Full Text] [Related]
15. Effect of Formalin Fixation for Near-Infrared Fluorescence Imaging with an Antibody-Dye Conjugate in Head and Neck Cancer Patients.
Kapoor S; Lu G; van den Berg NS; Krishnan G; Pei J; Zhou Q; Martin BA; Baik FM; Rosenthal EL; Nishio N
Mol Imaging Biol; 2021 Apr; 23(2):270-276. PubMed ID: 33078373
[TBL] [Abstract][Full Text] [Related]
16. Characterizing the Utility and Limitations of Repurposing an Open-Field Optical Imaging Device for Fluorescence-Guided Surgery in Head and Neck Cancer Patients.
Moore LS; Rosenthal EL; Chung TK; de Boer E; Patel N; Prince AC; Korb ML; Walsh EM; Young ES; Stevens TM; Withrow KP; Morlandt AB; Richman JS; Carroll WR; Zinn KR; Warram JM
J Nucl Med; 2017 Feb; 58(2):246-251. PubMed ID: 27587708
[TBL] [Abstract][Full Text] [Related]
17. Indocyanine green fluorescence-guided surgery in head and neck cancer: A systematic review.
De Ravin E; Venkatesh S; Harmsen S; Delikatny EJ; Husson MA; Lee JYK; Newman JG; Rajasekaran K
Am J Otolaryngol; 2022; 43(5):103570. PubMed ID: 35939987
[TBL] [Abstract][Full Text] [Related]
18. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using
Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X
Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096
[No Abstract] [Full Text] [Related]
19. Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence.
Gao RW; Teraphongphom NT; van den Berg NS; Martin BA; Oberhelman NJ; Divi V; Kaplan MJ; Hong SS; Lu G; Ertsey R; Tummers WSFJ; Gomez AJ; Holsinger FC; Kong CS; Colevas AD; Warram JM; Rosenthal EL
Cancer Res; 2018 Sep; 78(17):5144-5154. PubMed ID: 29967260
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of fluorescence-guided surgery agents in a murine model of soft tissue fibrosarcoma.
Prince AC; McGee AS; Siegel H; Rosenthal EL; Behnke NK; Warram JM
J Surg Oncol; 2018 May; 117(6):1179-1187. PubMed ID: 29284070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
